AJP - Heart Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 296: H1080-H1088, 2009. First published February 6, 2009; doi:10.1152/ajpheart.01093.2008
0363-6135/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Tables
Right arrow Buy
Right arrow All Versions of this Article:
296/4/H1080    most recent
01093.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sullivan, J. C.
Right arrow Articles by Pollock, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sullivan, J. C.
Right arrow Articles by Pollock, J. S.

Greater fractalkine expression in mesenteric arteries of female spontaneously hypertensive rats compared with males

Jennifer C. Sullivan,1 Jennifer L. Pardieck,1 Derek Doran,1 Yan Zhang,2 Jin-Xiong She,2 and Jennifer S. Pollock1

1Vascular Biology Center, 2Center for Biotechnology and Genomic Medicine, Medical College of Georgia, Augusta, Georgia

Submitted 13 October 2008 ; accepted in final form 2 February 2009

A mircoarray analysis was performed to identify novel inflammatory genes that are differentially expressed in the mesenteric arteries of male and female spontaneously hypertensive rats (SHRs). Fractalkine was found to be the inflammatory gene with the greatest differential expression in mesenteric arteries, with the expression being greater in female SHRs compared with males. Greater inflammatory mediators in female SHRs were verified by measuring urinary monocyte chemoattractant protein-1, transforming growth factor-β, and tumor necrosis factor-{alpha} (TNF-{alpha}) excretion, all of which were greater in female SHRs compared with males. Real-time PCR, Western blot analysis, and ELISA verified greater soluble fractalkine in mesenteric arteries of female SHRs. Consistent with increased fractalkine expression, TNF-{alpha}-converting enzyme and TNF-{alpha} levels in mesenteric arteries were also greater in female SHRs. We next tested the hypothesis that mesenteric arteries from female SHRs will have greater fractalkine-induced dysfunction. Acetylcholine, sodium nitroprusside, phenylephrine, and KCl concentration-response curves were performed in third-order mesenteric arteries from male and female SHRs pretreated with either vehicle or fractalkine (1 µg/ml). Fractalkine decreased sensitivity to 1) acetylcholine in arteries from male SHRs, 2) phenylephrine in arteries from both sexes, and 3) KCl in arteries from female SHRs. In conclusion, urinary and vascular markers of inflammation are greater in female SHRs compared with males, although blood pressure and cardiovascular risk are less in females.

hypertension; inflammation; sex difference; tumor necrosis factor-{alpha}; microarray



Address for reprint requests and other correspondence: J. C. Sullivan, Medical College of Georgia, 1459 Laney Walker Blvd., Augusta, GA 30912 (e-mail: jsullivan{at}mail.mcg.edu)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.